Pepton

The global antibiotic resistance crisis is advancing rapidly. Deaths related to multidrug-resistant bacteria infections are among the leading causes of deaths and disability worldwide. This is becoming a global concern since the medical community is rapidly running out of therapeutic options, creating an urgent need for innovative solutions. At Pepton, we design and develop cutting-edge molecules with bactericidal activity as a promising solution for these challenging infections. Our mission is to create a novel versatile platform for a continuous development of novel tools specifically designed to target bacterial agents that cause infections relevant to both human and veterinary health, without the risk of resistance emergence.